134 related articles for article (PubMed ID: 11266820)
1. Role of Fas-Fas ligand interaction in donor-specific transfusion-induced tolerance to H-Y antigen.
Minagawa R; Okano S; Tomita Y; Shimizu I; Iwai T; Kishihara K; Nomoto K; Sugimachi K; Nomoto K
Transplant Proc; 2001; 33(1-2):283. PubMed ID: 11266820
[No Abstract] [Full Text] [Related]
2. The critical role of Fas-Fas ligand interaction in donor-specific transfusion-induced tolerance to H-Y antigen.
Minagawa R; Okano S; Tomita Y; Kishihara K; Yamada H; Nomoto K; Shimada M; Maehara Y; Sugimachi K; Yoshikai Y; Nomoto K
Transplantation; 2004 Sep; 78(6):799-806. PubMed ID: 15385797
[TBL] [Abstract][Full Text] [Related]
3. Skin graft rejection elicited by beta 2-microglobulin as a minor transplantation antigen involves multiple effector pathways: role of Fas-Fas ligand interactions and Th2-dependent graft eosinophil infiltrates.
Surquin M; Le Moine A; Flamand V; Nagy N; Rombaut K; Demoor FX; Stordeur P; Salmon I; Guéry JC; Goldman M; Abramowicz D
J Immunol; 2002 Jul; 169(1):500-6. PubMed ID: 12077281
[TBL] [Abstract][Full Text] [Related]
4. Dominant tolerance and linked suppression induced by therapeutic antibodies do not depend on Fas-FasL interactions.
Honey K; Cobbold SP; Waldmann H
Transplantation; 2000 Apr; 69(8):1683-9. PubMed ID: 10836381
[TBL] [Abstract][Full Text] [Related]
5. Involvement of Fas and Fas ligand interaction in allogeneic hepatocyte rejection in the spleen.
Kawahara T; Kasai S; Yagita H; Kato K; Sawa M; Nakajima A; Azuma M; Okumura K; Futagawa S; Mito M
Transplant Proc; 1997 Jun; 29(4):2187-8. PubMed ID: 9193582
[No Abstract] [Full Text] [Related]
6. The role of Fas/FasL apoptotic pathway in the development of chronic rejection.
Subbotin V; Sun H; Aitouche A; Salam A; Valdivia LA; Fung JJ; Starzl TE; Rao AS
Transplant Proc; 1999; 31(1-2):1397-8. PubMed ID: 10083618
[No Abstract] [Full Text] [Related]
7. Fetal expression of Fas ligand is necessary and sufficient for induction of CD8 T cell tolerance to the fetal antigen H-Y during pregnancy.
Vacchio MS; Hodes RJ
J Immunol; 2005 Apr; 174(8):4657-61. PubMed ID: 15814689
[TBL] [Abstract][Full Text] [Related]
8. Perforin- and Fas-dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts.
Taylor MA; Ward B; Schatzle JD; Bennett M
Eur J Immunol; 2002 Mar; 32(3):793-9. PubMed ID: 11870623
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts.
Yoon IH; Choi SE; Kim YH; Yang SH; Park JH; Park CS; Kim Y; Kim JS; Kim SJ; Simpson E; Park CG
Transplantation; 2008 Nov; 86(10):1352-60. PubMed ID: 19034003
[TBL] [Abstract][Full Text] [Related]
10. Fas-mediated cytotoxicity is not required for rejection of murine nonvascularized heterotopic cardiac allografts.
Djamali A; Odorico JS
Transplantation; 1998 Dec; 66(12):1793-801. PubMed ID: 9884278
[TBL] [Abstract][Full Text] [Related]
11. Immune response and myoblasts that express Fas ligand.
Kang SM; Hoffmann A; Le D; Springer ML; Stock PG; Blau HM
Science; 1997 Nov; 278(5341):1322-4. PubMed ID: 9411754
[No Abstract] [Full Text] [Related]
12. Double-negative T cells, activated by xenoantigen, lyse autologous B and T cells using a perforin/granzyme-dependent, Fas-Fas ligand-independent pathway.
Zhang ZX; Ma Y; Wang H; Arp J; Jiang J; Huang X; He KM; Garcia B; Madrenas J; Zhong R
J Immunol; 2006 Nov; 177(10):6920-9. PubMed ID: 17082607
[TBL] [Abstract][Full Text] [Related]
13. CD47 is required for suppression of allograft rejection by donor-specific transfusion.
Wang H; Wu X; Wang Y; Oldenborg PA; Yang YG
J Immunol; 2010 Apr; 184(7):3401-7. PubMed ID: 20208011
[TBL] [Abstract][Full Text] [Related]
14. Contribution of Fas ligand to cardiac allograft rejection.
Seino K; Kayagaki N; Bashuda H; Okumura K; Yagita H
Int Immunol; 1996 Sep; 8(9):1347-54. PubMed ID: 8921411
[TBL] [Abstract][Full Text] [Related]
15. Induction of specific T cell tolerance by Fas ligand-expressing antigen-presenting cells.
Zhang HG; Su X; Liu D; Liu W; Yang P; Wang Z; Edwards CK; Bluethmann H; Mountz JD; Zhou T
J Immunol; 1999 Feb; 162(3):1423-30. PubMed ID: 9973398
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Fas ligand-induced apoptosis by TNF.
Elzey BD; Griffith TS; Herndon JM; Barreiro R; Tschopp J; Ferguson TA
J Immunol; 2001 Sep; 167(6):3049-56. PubMed ID: 11544288
[TBL] [Abstract][Full Text] [Related]
17. Purified donor T cells alone activate transplantation immunity to the male antigen but induce tolerance in combination with Mac-1+ donor cells.
Sheng B; McCormack WT; Smith RT
Transplantation; 1999 Oct; 68(7):1024-9. PubMed ID: 10532545
[TBL] [Abstract][Full Text] [Related]
18. Display of Fas ligand protein on cardiac vasculature as a novel means of regulating allograft rejection.
Askenasy N; Yolcu ES; Wang Z; Shirwan H
Circulation; 2003 Mar; 107(11):1525-31. PubMed ID: 12654611
[TBL] [Abstract][Full Text] [Related]
19. Fas/Fas ligand pathway, apoptosis, and clonal anergy involved in systemic acetylcholine receptor T cell epitope tolerance.
Deng C; Goluszko E; Christadoss P
J Immunol; 2001 Mar; 166(5):3458-67. PubMed ID: 11207304
[TBL] [Abstract][Full Text] [Related]
20. Tumour-induced immunity to H-Y-disparate skin grafts without concomitant priming of CTL.
Johnson LL; Hines DL
Immunology; 1990 Jan; 69(1):85-90. PubMed ID: 2312158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
